A new team joined MAxL at the end of 2024: OmicsDiscoveries!
The vision of OmicsDiscoveries is to facilitate and accelerate genetic testing. Through their advanced machine learning-based analysis of RNA sequencing data, they transform raw data into human-readable reports, supporting translational research.
OmicsDiscoveries provide an interactive analysis platform that integrates genetic variants, database annotations, clinical phenotypes, and RNA-based results, to support clinical geneticists in their daily tasks by facilitating and accelerating the time to interpret rare variants and find the root cause of rare diseases.
Targeted customers are labs and hospitals offering genetic testing. OmicsDiscoveries are dedicated to empowering geneticists to advance the frontiers of human genetics and rare disease research, ultimately leading to better and more precise diagnostics for patients.